STOCK TITAN

Insmed officer sells 101,100 shares, exercises options

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

INSMED Inc Chief People Strategy Officer Orlov S. Nicole Schaeffer exercised options on November 19, 2026, covering 55,400 shares at an exercise price of $30.46 and 45,700 shares at an exercise price of $26.43. She also reported sales of 90,299 shares at a weighted average price of $145.06, 8,539 shares at $146.76, and 2,262 shares at $147.50. The reported transactions were made under a Rule 10b5-1 trading plan adopted May 11, 2026.

Insider Schaeffer Orlov S Nicole
Role Chief People Strategy Officer
Sold 101,100 shs ($14.69M)
Approx. gross sale proceeds $14.69M
Approx. exercise cost $2.90M
Approx. pre-tax spread $11.79M
Share of Position Sold 70.7%
Type Security Shares Price Value
Exercise Stock Option (right to buy) F1, F6 55,400 $0.00 $0.00
Exercise Stock Option (right to buy) F1, F6 45,700 $0.00 $0.00
Exercise Common Stock F1, F2 55,400 $30.46 $1.69M
Exercise Common Stock F1 45,700 $26.43 $1.21M
Sale Common Stock F1, F3 90,299 $145.06 $13.10M
Sale Common Stock F1, F4 8,539 $146.76 $1.25M
Sale Common Stock F1, F5 2,262 $147.50 $334K
Holdings After Transaction: Stock Option (right to buy) — 0 options (Direct); Common Stock — 41,895 shares (Direct)
Holdings Before and After: Stock Option (right to buy), 101,100 to 0 options (Direct); Common Stock, 41,895 to 41,895 shares (Direct)
Footnotes (6)
  1. F1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2. Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
  3. F3. This is the weighted average sales price representing 90,299 shares sold at prices ranging from $145.00 to $145.93 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4. This is the weighted average sales price representing 8,539 shares sold at prices ranging from $146.10 to $147.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5. This is the weighted average sales price representing 2,262 shares sold at prices ranging from $147.38 to $148.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6. The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
Options exercised 55,400 shares at an exercise price of $30.46 November 19, 2026
Options exercised 45,700 shares at an exercise price of $26.43 November 19, 2026
Shares sold 90,299 shares at a weighted average price of $145.06 per share November 19, 2026
Shares sold 8,539 shares at a weighted average price of $146.76 per share November 19, 2026
Shares sold 2,262 shares at a weighted average price of $147.50 per share November 19, 2026
Rule 10b5-1 trading plan regulatory
"under a Rule 10b5-1 trading plan adopted May 11, 2026"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sales price financial
"weighted average sales price representing 90,299 shares sold"
Stock Option (right to buy) financial
"Stock Option (right to buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many INSM shares did Chief People Strategy Officer Orlov S. Nicole Schaeffer sell?

She reported three sales totaling 101,100 shares on November 19, 2026: 90,299 at a weighted average price of $145.06, 8,539 at $146.76, and 2,262 at $147.50. The reported transactions were made under a Rule 10b5-1 trading plan adopted May 11, 2026.

What INSM options did Orlov S. Nicole Schaeffer exercise, and at what prices?

She exercised options covering 55,400 shares at $30.46 and 45,700 shares at $26.43 on November 19, 2026. The options were exercisable, and the transactions were reported under a Rule 10b5-1 trading plan adopted May 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schaeffer Orlov S Nicole

(Last)(First)(Middle)
700 US HIGHWAY 202/206

(Street)
BRIDGEWATER NEW JERSEY 08807

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
INSMED Inc [ INSM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief People Strategy Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/19/2026M(1)55,400A$30.4697,295(2)D
Common Stock11/19/2026M(1)45,700A$26.43142,995D
Common Stock11/19/2026S(1)90,299D$145.06(3)52,696D
Common Stock11/19/2026S(1)8,539D$146.76(4)44,157D
Common Stock11/19/2026S(1)2,262D$147.5(5)41,895D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$30.4611/19/2026M(1)55,400 (6)01/04/2028Common Stock55,400$00D
Stock Option (right to buy)$26.4311/19/2026M(1)45,700 (6)01/06/2032Common Stock45,700$00D
Explanation of Responses:
1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
2. Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
3. This is the weighted average sales price representing 90,299 shares sold at prices ranging from $145.00 to $145.93 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
4. This is the weighted average sales price representing 8,539 shares sold at prices ranging from $146.10 to $147.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
5. This is the weighted average sales price representing 2,262 shares sold at prices ranging from $147.38 to $148.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
6. The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
Remarks:
/s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact11/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading